AbbVie

Open: 148.95 Close: 147.96 Change: -0.99

You're running out of time to find out about AbbVie Company Inc using an AI.

This document will help you to evaluate AbbVie without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, company, stock, dividend, Inc, ABBV, Abbvie, and the …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked sites. The Yes link below will take you out of the family of websites.

Today's News

AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years. Since the companies inception in 2013, Abbvie has increased its dividend by 270 percent. RINVOQ is a selective JAK inhibitor that is being studied in several immune-mediated inflammatory diseases. AbbVie is committed to cutting-edge research to drive exciting developments in inflammatory bowel diseases. AbbVie announced top-line results from the Phase 3 SEQUENCE clinical trial evaluating risankizumab (SKYRIZI) versus ustekinumab in Crohns disease. Skyrizi met all primary and secondary endpoint. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site. The Yes link below will take you out of the family of websites. European Commission grants conditional marketing authorization for TEPKINLY (epcoritamab) for adult patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) European Commission granted conditional marketing approval for Tepkinly. AbbVie announced Skyrizi (risankizumab) met the primary and key secondary endpoints in a 52-week Phase 3 maintenance study in patients with moderately to severely active ulcerative colitis (UC) The FDA approved Epkinly (epcoritamab) as the first bispecific antibody. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties. The company undertakes no obligation to release publicly any revisions. AbbVie Inc. (ABBV) stock price, quote & news - stock analysis. Abbvie has been aggressive in shaping its own neuroscience pipeline. AbbVie to present at Morgan Stanley Healthcare Conference on September 13, 2023. SKYRIZI (risankizumab) Met all Primary and Secondary Endpoints Versus Stelara® (ustekinumab), in Head-to-head Study in Crohns Disease. AbbVie Inc. per Employee $1.120M P/E Ratio 30.39 EPS $4.87 Yield 4.00% Dividend & Yield $5.92 (4.00%) ABBV stock price | abbvie inc. stock quote (u.s.: nyse) | marketwatch. Abbv: abbvie inc - stock price, quote and news - cnbc.com - CNBC. ABBV: AbBvie Inc - Stock Price, Quote and News. AbbVie Pharmaceutical Manufacturing North Chicago, Illinois 1,249,936 employees Join now. AbbVie Inc.s (ABBV) dividend yield is 4%, which means that for every $100 invested in the stock, investors would receive $4.00 in dividends per year. The companys payout ratio is 118.55%. AbbVies Phase 2b study evaluating upadacitinib (RINVOQ) in adults with non-segmental vitiligo (NSV) met primary endpoint of percent change from baseline in Facial Vitiligo Area Scoring Index (F-VASI) at week 24 with the 11 mg and 22 mg doses. AbbVie donates $100 million to Ronald McDonald House Charities to help more families thrive. Learn more about this historic gift to @RMHC. AbbVie announced a $50 million donation to @StJude. Together, we must be a force for driving accountability and change that we need to see in our society. AbbVie ranked #1 on the 2019 #BestWorkplaces in Biopharma list by @FPTW_US and @fortunemagazine. The company values are grounded in inclusion and acceptance. AbbVie has a market cap of $261 billion. The company has a worlds most valuable stock portfolio. Abbvie Inc paid out 119.9% of its earnings over the trailing twelve months. ABBV pays a dividend of $5.92 per share. The company has released long-term efficacy and safety data from three Phase III trials investigating Rinvoq in moderate-to-severe atopic dermatitis. AbbVie Inc. (ABBV-N) still controls more than 97% of the us market – endpoints news. Abbvie drug price connection touted by chamber in updated suit.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

How much time have you spent trying to decide whether investing in AbbVie? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, company, stock, dividend, Inc, ABBV, Abbvie, and the most common words in the summary are: abbvie, stock, dividend, abbv, news, job, market, . One of the sentences in the summary was: The Yes link below will take you out of the family of websites.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #stock #dividend #abbv #news #job #market.